Resistance to adenovirus infection after administration of Bordetella pertussis vaccine in mice.
AUTOR(ES)
Winters, A L
RESUMO
Treatment of mice with Bordetella pertussis vaccine rendered mice resistant to mouse adenovirus infection. The resistant state took at least 5 days to develop, and susceptibility returned to a portion of the test population 35 days after treatment. Transient resistance developed in congenitally athymic mice also. Treatment with a dose of 25 micrograms (dry weight) of B. pertussis vaccine protected approximately 50% of the test population. Vaccines prepared from several different strains of B. pertussis were capable of inducing resistance, and the induction of resistance was not dependent on the mouse strain used for testing. Cross-reacting antibodies capable of neutralizing the virus or protecting against a challenging infection were not induced by treatment with B. pertussis vaccine.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=261326Documentos Relacionados
- Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.
- THE ALTERED REACTIVITY OF MICE AFTER INOCULATION WITH BORDETELLA PERTUSSIS VACCINE1
- Biological activity of Bordetella pertussis in lipopolysaccharide-resistant mice.
- Sensitization of Mice by Inhalation of Antigen After Infection with Bordetella pertussis
- Adjuvant effect of Bordetella pertussis vaccine to sheep erythrocytes in mice: enhancement of cell-mediated immunity by subcutaneous administration of adjuvant and antigen.